ARTELO BIOSCIENCES, INC. (ARTL)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ARTELO BIOSCIENCES, INC. chart...

About the Company

We do not have any company description for ARTELO BIOSCIENCES, INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

10

Exchange

Nasdaq

$12M

Total Revenue

10

Employees

$4M

Market Capitalization

-0.80

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARTL News

Artelo Biosciences Inc ARTL

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

25d ago, source: Business Insider

SOLANA BEACH, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge

1mon ago, source: Nasdaq

SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to ...

Artelo Biosciences, Inc. (ARTL)

4d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

26d ago, source: ADVFN

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain ...

Artelo Biosciences Inc. Wt

23d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Artelo Biosciences Inc ARTL

16d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Artelo Biosciences Inc.

23d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Artelo Biosciences Inc (ARTL)

4d ago, source: Investing

Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Industrials and Healthcare sectors led shares higher while losses in the Utilities, ...

Artelo Biosciences Inc (ARTL)

24d ago, source: Investing

SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company, has been selected as a finalist in the Johnson & Johnson... Artelo Biosciences, Inc., a ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...